EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JUL 2022
TABLES
147
PAGES
577
EDITION
19
PRICE
USD 5600
CODE
MCP-1029
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Global Proteomics Market to Reach $43.5 Billion by 2026
The proteomics market is anticipated to gain from the pressing need to develop advanced therapeutic and diagnostic options in the wake of COVID-19. The ability of proteomics to help researchers in detecting several proteins in a single analysis is anticipated to make it a suitable weapon in the fight against the COVID-19 virus. Proteomics represents a highly relevant technique in the battle against COVID-19 owing to the significance to understand the role played by proteins in the infection process as well as disease progression. These insights are critical to support preventative strategies and development of novel therapeutics. The use of mass spectrometry to detect COVID-19 virus` proteins and proteolytic peptides enables a rapid, simple virus detection assay. On the other hand, targeted proteomics allows detection of peptides of the virus` spike proteins and nucleocapsid with high specificity and sensitivity in clinical and research samples. The approach holds potential to make proteomics an effective option for diagnostic laboratories along with point-of-care testing as a cost-effective alternative to techniques based on nucleic acid. Proteomics can be potentially used to develop techniques to predict COVID-19 patients who may experience severe symptoms later. Various studies have revealed potential protein-based biomarkers expressed differently among certain COVID-19 patients, which can be used for predicting viral infection during earlier stages. The use of proteomics to understand humoral antibody response against virus` proteins has facilitated the development of specific antibody-based assays intended to support diagnostic or therapeutic objectives.
Amid the COVID-19 crisis, the global market for Proteomics estimated at US$30.2 Billion in the year 2022, is projected to reach a revised size of US$43.5 Billion by 2026, growing at a CAGR of 10.8% over the analysis period. Reagents, one of the segments analyzed in the report, is projected to grow at a 10.6% CAGR to reach US$34.8 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 11.8% CAGR for the next 7-year period. This segment currently accounts for a 17.2% share of the global Proteomics market.
The U.S. Market is Estimated at $11.5 Billion in 2022, While China is Forecast to Reach $3.9 Billion by 2026
The Proteomics market in the U.S. is estimated at US$11.5 Billion in the year 2022. The country currently accounts for a 37.7% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$3.9 Billion in the year 2026 trailing a CAGR of 13.6% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.2% and 10.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.3% CAGR while Rest of European market (as defined in the study) will reach US$4.3 Billion by the close of the analysis period.
Major driving factors of growth in the market include growing demand for personalized medicine, growing applications of proteomics in drug discovery, rise in demand for early diagnosis and treatment of diseases, technical advancements, rise in birth disorders and genetic disorders and the rapidly growing pharmaceutical and biopharmaceutical markets. Other factors supporting growth include development of protein targeted treatments and precision molecular medicines for many autoimmune diseases, development of mass spectrometry-based proteomics, and development of molecular targets in malignancies. Increasing focus of biotechnological and pharmaceutical companies in research and development for identifying new proteomics applications, development of new drugs, and proteomics biomarker discovery in different types of diseases such as cardiovascular diseases and cancer is the major trend in the global proteomics landscape. Proteomics is extensively used in protein expression profiling, targeted protein quantitation, analysis of interactions between proteins, and post-translational modification in different segments of the pharmaceutical industry. Advanced proteomics solutions are finding extensive application in diagnostic services, drug discovery and other research fields. Proteomics is a promising approach towards personalized medicine to treat several diseases, such as diabetes, obesity, fatty liver, neurological diseases, and cancer.
In addition to the rising incidence of cancer, diabetes, and other potentially fatal diseases, there is a rise in disorders, such as autism and Alzheimer`s, which are highly wanting in terms of research and cure. Use of plasma proteomics method for proteomic biomarker identification is associated with challenges of patients` variation and high dynamic range of plasma proteins. However, increasing focus on specialty medicines due to technological advancements, sophisticated software, and tools such as IoT, data analytics, big data, and artificial intelligence in the clinical research related to proteomics could create new opportunities for the proteomics market. The sustained increase in the popularity of personalized medicine and protein therapeutics, together with the availability of newly developed proteins, is projected to increase the demand for proteomic technologies in drug development processes and as diagnostic tools, driving growth of the market.
Services Segment to Reach $3.3 Billion by 2026
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion will reach a projected size of US$2.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$314.8 Million by the year 2026.
SELECT PLAYERS
ActivX Biosciences, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Bruker Corporation; Cytiva; Geneva Bioinformatics S.A.; Merck KGaA; PerkinElmer, Inc.; Shimadzu Corporation; Millipore Sigma; Thermo Fisher Scientific, Inc.; Waters Corp.; Xencor, Inc.
SEGMENTS
» Component (Reagents, Instruments, Services) » Application (Drug Discovery, Disease Diagnosis, Other Applications)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Middle East » Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
2020: A Year of Disruption & Transformation |
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021? |
Impact of COVID-19 on Laboratory Equipment and Supplies Market: A General Review |
Proteomics Emerges as an Important Research Tool in Battle against COVID-19 |
Pressing Need for COVID-19 Diagnostics & Therapeutics Accentuates Dynamic Role of Proteomics |
Gaining Insights into COVID-19 & Drug Discovery with Proteomics |
Proteomics to Enable Potent Antiviral Agents & Better Vaccines against COVID-19 |
Proteomics Labs Explore COVID-19 Therapeutic Options, Dx Development |
Proteomics – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
Proteins, Proteome and Proteomics: A Prelude |
Genesis of Proteomics |
Important Milestones |
An Insight into Proteomics Data Type and their Characteristics / Features |
Proteomics and Genomics: A Comparison |
Applications of Proteomics |
Outlook |
Proteomics at the Fore with Latest Advances |
Regional Analysis |
Key Challenges to Address |
Sparse and Difficult to Measure Data |
Democratizing Proteomics |
Absence of High-Profile Projects for Stimulating Interest |
Creating Novel Experimental Design |
Lack of Commercialization of High Throughput Impacts |
Lack of Necessary Technical Skillset |
Competition |
Recent Market Activity |
World Brands |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Proteomics Profiling to Expedite Drug Discovery |
Other Applications of Proteomics in Drug Discovery |
New Proteomics Technique to Aid Drug Screening & Biomarker Discovery |
Diseases as a Major Cause of Deaths Worldwide Brings to Fore the Growing Importance of New Breakthroughs in Proteomics-Based Technologies: Top Global Causes of Death (In Millions) by Type of Disease for the Years 2000 and 2019 |
EXHIBIT: Global Drug Discovery Market by Segment: 2020 |
Growing Interest in Personalized Medicine to Drive Market Growth |
EXHIBIT 8: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025 |
Oncology: A Key Focus Area for Proteomics |
EXHIBIT 3: Global Breakdown of Total Number of Cancer Cases by Type: 2020 |
EXHIBIT 4: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040 |
Proteomic Approaches Gain Prominence in Cancer Drug Discovery |
Proteomics Technologies Used in Cancer Drug Discovery and Development |
Role of Proteomics in Oncology Biomarker Discovery |
TABLE: List of FDA-approved Protein Biomarkers for Cancer |
Advancements in Proteomics Bring Biomarkers into Limelight |
Different Types of MS-Based Proteomic Discovery Techniques for Biomarkers |
Affinity-Reagent-Array-Based Techniques |
Affinity-and-Antibody-Based MS Techniques |
CE-MS Technology: An Emerging Technology for Discovery of Biomarkers |
Protein Microarrays: A Novel Tool for the Development of Pharmaceuticals |
Protein Microarray Formats |
New Technologies Expand Application of Proteomics |
DIA Technique for Protein Discovery |
AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns |
Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction |
Map of COVID-19 and Human Protein Interactions Reveals Drug Targets |
Single-Cell Proteomics Offers a Better Understanding of Cellular Identity |
Metalloproteomics: A Rapidly Evolving Field |
Post-translational Modification of Proteins Increases Functional Diversity of Proteome |
Pharmacoproteomics Holds Significant Prospects in Precision Medicine |
Increasing Prominence of Nanoproteomics Widens Opportunities |
Global Proteomics Sample Preparation Market |
Challenges Faced |
Management of Data in Proteomics Research Poses a Big challenge |
Role of Contract Research Organizations to Increase in Proteomics |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Disease Diagnosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Disease Diagnosis by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
JAPAN |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
CHINA |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
China Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
EUROPE |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Proteomics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
FRANCE |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
France Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
GERMANY |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Proteomics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027 |
AUSTRALIA |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E) |
Australia Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Australia Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
INDIA |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
India Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
India Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
SOUTH KOREA |
South Korea Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
South Korea Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
LATIN AMERICA |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
Latin America Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
MIDDLE EAST |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
Middle East Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Middle East Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
AFRICA |
Proteomics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E) |
Africa Recent Past, Current & Future Analysis for Proteomics by Component - Reagents, Instruments and Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Proteomics by Component - Reagents, Instruments and Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Proteomics by Component - Percentage Breakdown of Value Revenues for Reagents, Instruments and Services for the Years 2012, 2021 & 2027 |
Africa Recent Past, Current & Future Analysis for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Proteomics by Application - Drug Discovery, Disease Diagnosis and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Proteomics by Application - Percentage Breakdown of Value Revenues for Drug Discovery, Disease Diagnosis and Other Applications for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 178 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com